Clare Cruickshank

Medicine · Health Sciences

14h-index2.5kcitations35works0.22yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(18), Prostate Cancer Diagnosis and Treatment(17), Advanced Radiotherapy Techniques(7), Bladder and Urothelial Cancer Treatments(5), Statistical Methods in Clinical Trials(5)

Publications35 total

A phase 3 randomised controlled trial of proton beam therapy for oropharyngeal cancer
Research Explorer (The University of Manchester)·2026Open Access
Supportive Care Needs of Patients with Breast Cancer Who Self-Identify as Black: An Integrative Review
Current Oncology·2025Open Access
Tracing impact: building capacity in patient-oriented primary care research in Ontario and beyond
The Annals of Family Medicine·2024Open Access
Am I attached? A patient-partnered approach to creating infographics about attachment to primary care in Ontario, Canada
Research Involvement and Engagement·2024· 1 citedOpen Access
 Am I attached? A patient-partnered approach to creating infographics about attachment to primary care in Ontario, Canada
2024Open Access
1221: Using routinely collected data for long term toxicity assessment; a case-study from the CHHiP trial
Radiotherapy and Oncology·2024
Working with patients to co-produce visualizations comparing local and regional rates of attachment to primary care
2023Open Access
International Society of Urological Pathology ( <scp>ISUP)</scp> Gleason Grade Groups stratify outcomes in the <scp>CHHiP</scp> Phase 3 prostate radiotherapy trial
British Journal of Urology·2023· 2 citedOpen Access
10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016).
Journal of Clinical Oncology·2023· 24 cited
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
Clinical and Translational Radiation Oncology·2022· 21 citedOpen Access
PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
Clinical and Translational Radiation Oncology·2022· 13 citedOpen Access
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)
European Urology·2022· 57 citedOpen Access
PEARLS: A multicenter phase II/III trial of extended field radiotherapy for androgen-sensitive prostate cancer patients with PSMA‐avid pelvic and para-aortic lymph nodes at presentation.
Journal of Clinical Oncology·2022· 2 cited
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis
British Journal of Cancer·2021· 11 citedOpen Access
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
European Urology Oncology·2021· 38 citedOpen Access
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
Clinical and Translational Radiation Oncology·2020· 49 citedOpen Access
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
BMC Medical Research Methodology·2020· 6 citedOpen Access
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.
Journal of Clinical Oncology·2020· 8 cited
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
Clinical and Translational Radiation Oncology·2019· 32 citedOpen Access
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Radiotherapy and Oncology·2019· 48 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Emma Hall(26), Clare Griffin(20), David P. Dearnaley(16), Isabel Syndikus(16), John Staffurth(14), Miguel Panades(11), Vincent Khoo(10), Christopher Scrase(10), Shama Hassan(9), Alison Birtle(8), Chris Parker(8), Olivia Naismith(8), Anna Wilkins(8), John D. Graham(7), Helen Mossop(6), Joe M. O’Sullivan(6), Alison Tree(6), John Logue(5), Zafar Malik(5), Helen Mayles(5)